8th International Congress of
Neuroimmunology
free
papers
October 15-19, 2006
- Nagoya Japan
|
|
|
|
INDEX
MS: Clinical aspect and
immune response
Characteristics of Late-onset Multiple Sclerosis
M. Kondo, Y. Nagakane, N. Kuriyama, T.
Tokuda, T. Mizuno and M. Nakagawa
A Case Report of the Patient with Tumefactive
Demyelinating Lesion Masqueraded Brain Tumor
M. Apiwattanakul, T. Tantirittisak, S.
Phudhichareonrat and R. Kunnatiranont
Coincidence of Multiple Sclerosis and Autoimmune
Diseases
J. Szilasiová, Z. Gdovinová and Z. Macejová
Percentage of CD4+CD25+ Cells in Cerebrospinal Fluid:
Reliable Immune Parameter for Disease Activity in Relapsing-Remitting
Multiple Sclerosis
M. Matsui, S. Araya, H.-Y. Wang, K. Ozawa,
E. Nishiguchi, M. Matsui, M. Nakanishi, M. Kaito, Y. Gondo and T. Saida
Altered Naïve CD4 T Cell Homeostasis in
Relapsing-Remitting Multiple Sclerosis Due, in Part, to Peripheral
Mechanisms
D.A. Duszczyszyn, J. Hackenbroch, H. Mason,
J.P. Antel, Y. Lapierre and D.G. Haegert
Both Aquaporin-1 (AQP1) and Aquaporin-4 (AQP4) Are
Expressed in Cultured Human Astrocytes and Non-hypertrophic Astrocytes
in Brains of Multiple Sclerosis
Jun-ichi Satoh and Hiroko Tabunoki
Programmed Cell Death and Expression of Apoptotic
Genes in Multiple Sclerosis Patients
M. Saresella, I. Marventano, R. Mancuso, R.
Mazziotti, R. Cavarretta, D. Caputo, R. Longhi and P. Ferrante
Axonal Damage Targets Inflammatory Demyelinating
Lesions to Sitesof Wallerian Degeneration: Inside-out Model for Multiple
Sclerosis
I. Tsunoda, T. Tanaka, Y. Saijoh, S.E.
Doyle, E.J. Terry and R.S. Fujinami
Anti-Nogo Receptor Autoantibody in the Serum of
Multiple Sclerosis
J. Satoh and H. Onoue
MS: treatment and immune
regulation
Levels of Serum IgM Antibody Against Native Refolded
MOG Predict Responsiveness To Corticosteroids for Treatment of Acute
Multiple Sclerosis Relapses
M. Khalil, B. Kuenz, A. Lutterotti, R.
Ehling, C. Gneiss, R. Egg, I. Mayringer, F. Deisenhammer, M. Reindl and
T. Berger
Detection of NK-cells as Putative Regulators of
Multiple Sclerosis Disease Activity During and After Pregnancy
L. Airas
Flow Cytometric Analysis of Natural Killer Receptor+
T Cells in Multiple Sclerosis
J. O’Keeffe, C. Gately, T. Counihan, M.
Henessey, T. Leahy, E. Ali, A.P. Moran and E.L. Hogan
Functional Deficit in CD4+CD25+ T Cells from MS
Patients
Y.C.Q. Zang, J. Hong, S. Skinner, J.M.
Killian and J.Z. Zhang
DNA Microarray Analysis Identifies CXCR3 and CCR2
Ligand Chemokines as Early IFN-responsive Genes in Peripheral Blood
Lymphocytes
Jun-ichi Satoh and Yusuke Nanri
Analysis of Neutralizing Antibodies in the BEtaferon®
in Newly Emerging Multiple Sclerosis For Initial Treatment (BENEFIT)
Study
M. Freedman, L. Kappos, C. Polman, H.-P.
Hartung, G. Edan, D. Miller, X. Montalban, L. Bauer, S. Dahms, C. Pohl
and R. Sandbrink
IFN- b
Counteracts the Apoptosis Induced by TNF in Astrocytes Through
Stimulation of PI-3K and MEK
O. Barca, J.A. Costoya, R.Mª Señarís and
V.M. Arce
The Effects of Interferon- b1b
on Expression of CXCR3 on Circulating T Cells in Multiple Sclerosis
Paients
H. Nakajima, T. Hosokawa, M. Sugino, F.
Kimura, T. Hanafusa, T. Ikemoto and A. Shimizu
Enhancing Effects of Gasoline and Diesel Vapor on
Intrahepatic Natural Killer T Cells
I. Mrakovèiæ-Šutiæ,
D. Grebiæ,
H. Jakovac and B. Radoševiæ-Stašiæ
Peripheral Blood Mononuclear Cells Immunophenotyping
in Multiple Sclerosis Patients After Natalizumab Treatment in Comparison
with Immunoablation with Autologous Hematopoietic Stem Cells
Transplantation Treatment
E. Krasulova, E. Havrdova, H. Mareckova and
Z. Vankova
Experimental autoimmune
encephalomyelitis
The role of Urokinase Receptor in Experimental
Autoimmune Encephalomyelitis, an Animal Model of Multiple Sclerosis
C. Schaefer, V. Evans, S. Takahashi, Y. Xu,
C. Mallari, A. Citkowicz, B. Larsen, Y. Zhu, M. Bao, C. Wagner, E. Croze,
H. Salamon, E. Ho, J.-L. Tseng, D. Vogel, H. Dinter and H.-T. Lu
HLA Class-II transgenic Mice Expressing Class-II on
Subset of CD4+T Cells as a Model of Human MS
A. Mangalam, M. Rodriguez and C. David
SJA6017 Attenuates Immune Cell Infiltration and
Neurodegeneration in EAE
M.K. Guyton, A. Das, D.D. Matzelle, S.
Samantaray, M. Azuma, J. Inoue, S.K. Ray and N.L. Banik
Prevention of EAE Through Induction of Treg Cells by
Transfer of ES-DC-TRAIL/MOG
S. Hirata, S. Senju, H. Matsuyoshi, D.
Fukuma and Y. Nishimura
Fingolimod (FTY720), Sphingosine 1-Phosphate Receptor
Modulator, Ameliorates Experimental Autoimmune Encephalomyelitis (EAE)
I. Effect of FTY720 and FTY720-Phosphate on Myelin Proteolipid
Protein-Induced EAE in SJL/J Mice
H. Kataoka, K. Sugahara, K. Shimano, Y.
Maeda, M. Koyama, A. Fukunari and K. Chiba
Fingolimiod (FTY720), Sphingosine 1-phosphate
Receptor Modulator, Ameliorates Experimental Autoimmune
Encephalomyelitis (EAE) II. Effect of FTY720 on Myelin Oligodendrocyte
Glycoprotein- Induced EAE in C57BL/6 Mice
N. Seki, H. Kataoka, M. Ohtsuki, N. Sato,
A. Fukunari, K. Sugahara and K. Chiba
Guillain-Barré syndrome and
related disorders
Efficacy of Immunoglobulin and Steroid to Variant
Type Guillain-Barré Syndrome: in vitro Study of the MEPP Frequency
Increase
M. Kishi, K. Kumamoto, K. Saita, K. Shioya,
M. Nakazato and T. Kurihara
Long-term Prognosis of Guillain-Barre Syndrome
M. Ogino, Y. Ogino, S. Irie, N. Kanazawa,
T. Saito and F. Sakai
CD1E Polymorphism in Chronic Inflammatory
Demyelinating Polyneuropathy (CIDP)
G. Lee, X.K. Zhou, D. Latov, T.H. Brannagan,
R.L. Chin, H.W. Sander and N. Latov
NMJ-inhibitory Anti-GD3 Antibody in AIDP and CIDP
S. Usuki, J. Sanchez, T. Ariga, I.
Utsunomiya, K. Taguchi, Y. Nakatani, M.H. Rivner and R.K. Yu
Myasthenia Gravis: Treatment
and immune responses
Treatment with Tacrolimus in Elderly Patients with
Myasthenia Gravis
H. Takahashi, N. Kawaguchi, Y. Nemoto and
T. Hattori
Elevation of IL-12 p40 and Its Antibody Is a Specific
Serum Marker for Myasthenia Gravis with Thymoma
H. Yoshikawa, K. Satoh, Y. Motozaki, S.
Edahiro, Y. Furukawa, T. Maruta, K. Iwasa, M. Yamada, H. Watanabe and M.
Takamori
Tacrolimus as a Treatment for Severe Myasthenia
Gravis
K. Kamakura, M. Kanzaki, G. Ogawa, H.
Mochizuki, K. Kaida and K. Motoyoshi
Effect of Thymectomy on Late Onset Non-Thymomatous
Myasthenia Gravis
N. Kawaguchi, S. Kuwabara, Y. Nemoto, T.
Fukutake, K. Arimura, M. Osame and T. Hattori
Long Term Effect of Infrasternal Mediastinoscopic
Thymectomy on Myasthenia Gravis
H. Murai, A. Uchiyama, F. Mei, N. Shi, M.
Kojima and J. Kira
DNA Microarray Analyses: New Drug Targets for
Myasthenia Gravis
T. Feferman, R. Aricha, P.K. Maiti, G.
Clairac, M. Cuvelier, S. Berrih-Aknin, S. Fuchs and M.C. Souroujon
CD21 and Ki-67 Expression in Thymus of Patients with
Myasthenia Gravis and their Correlation with Clinical Parameters
J. Ikeda, T. Nishisaka, T. Kohriyama, H.
Tokinobu, E. Imamura and M. Matsumoto
A Study of the Factors Inducing the Development or
Recurrence of Childhood-onset MG Using CDR3 Spectratyping Analysis of
the TCR Repertoire
N. Shinomiya, J. Nakazato, H. Dokai, Y.
Fujikawa, K. Nihei, Y. Nomura and M. Segawa
In vitro and in vivo Characterization of
Subunit-Specific Acetylcholine Receptor Autoantibodies from Myasthenia
Gravis Patients
K. Poulas, S. Sideris, G. Kordas, G.
Lagoumintzis, P. Tsiamalos, A. Sotiriadis, I. Gavra, K. Kostelidou and
S.J. Tzartos
Studies on Myoid Cells in Hyperplastic Myasthenia
Gravis
I. Kamo, H. Tomoyasu, M. Kobayashi, N.
Sakuragawa, S. Inoue, T. Hagiwara, T. Kaneda and A. Kikuchi
Comparative Analysis of Two Different Assays in the
Detection of anti-MuSK Antibodies
M. Marino, F. Scuderi, C. Provenzano, A.
Evoli and E. Bartoccioni
Immune-mediated muscle
disorders
Usefulness of MRI Orientated Muscle Biopsy (MOMB) for
Diagnoses of Inflammatory Myopathies
S. Matsubara, K. Kondo, K. Sugaya, E.
Isozaki, K. Miyamoto, A. Yagishita, T. Mizutani and K. Hiramatsu
The Role of Granulysin in Muscle Fiber Injury in
Polymyositis
S. Okada, H. Nemoto, M. Nishina, T.
Kurihara, T. Morishita
Phenotypic Analysis of Lymphocytes Using Flow
Cytometry in Dermatomyositis with and without Interstitial Pneumonia
Y. Shimojima, M. Matsuda, W. Ishii, T. Gono,
K. Tazawa, T. Yoshida, N. Kato and S. Ikeda
Human Myoblasts Secrete MCP-1 and IL-6 and Express
ICAM-1 in Response to Hyper-IL-6 in vitro
M. Marino, F. Scuderi, C. Provenzano, J.
Scheller, S. Rose-John and E. Bartoccioni
Paraneoplastic syndrome and
autoantigens
Examining Pathogenicity of Anti-enolase Antibodies in
Paraneoplastic and Autoimmune Retinopathy
T. Anekonda, L. Karren, R.G. Weleber and G.
Adamus
The Clinical Characteristics of 38 Patients with
Definite Diagnosis of Paraneoplastic Neurological Syndrome
G. Gromadzka, Z. Lysiak and A. Czlonkowska
Autoantibodies in Stiff-person Syndrome and Other
Paraneoplastic Neurological Disorders
A. Ishii, Ohkoshi, A. Hayashi, H. Tsuji, A.
Oda, A. Mochizuki, K. Ishii, M. Watanabe and A. Tamaoka
Expression and Distribution of Vascular Endothelial
Growth Factor (VEGF) and Its Receptors in POEMS Syndrome
Teruaki Kawasaki, Nobuyuki Oka, Hidekazu
Tomimoto, Kotarou Mizutani, Ichiro Akiguchi and Hiroshi Nishitani
State of Autoantigen B23 in Human Tumor Cells
N.M. Vladimirova, E.G. Manuylova, N.V.
Stratiyenko and E.N. Sautkina
Early Onset Gluten Ataxia – Case Report
J. Szilasiová and Z. Gdovinová
Virus-induced neurological
diseases
The Association of Leader Protein of Theiler’s Murine
Encephalomyelitis Virus with Clathrin-Associated Protein AP50
K. Asakura, Y. Kontani and Y. Ohara
Generation of a Mutant of Theiler’s Murine
Encephalomyelitis Virus (TMEV) Causing Demyelination in the Brain of
Susceptible Mice
T. Okuwa, M. Takano-Maruyama, K. Asakura,
H. Murayama and Y. Ohara
Antigen Presentation by Glia During CNS Infection
K.E. Malone, L. Hamo, S.A. Stohlman and
C.C. Bergmann
Determinants for Spongiform Encephalopathy by A8
Murine Leukemia Virus
S. Takase-Yoden and R. Watanabe
Allicin and Its Derivative Induce Apoptosis of
HTLV-I-infected Cells Derived from Patients with HTLV-I-associated
Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
Y. Nishiura, T. Nakamura, N. Fukushima, H.
Ida and K. Eguchi
Neuro-immune interaction,
stress
Compartmentalized Immune Response in the Barrel Field
of the Mouse Primary Somatosensory Cortex
J. Perez-H, G. Gutiérrez-Ospina, C.
Ortiz-Martínez, M. Cerbón and A. Chavarria
Effect of Magnetic Stimulation Over Left
Temporo-parieto-occipital Cortex on Human Blood T Cell Distributions and
Serum IgE Responses
M. Nowakowski, V.E. Amassian, Y. Moshel and
H.G. Durkin
Transcriptional Expression and Functional Activity of
Mu-opioid Receptors (MOR) on Myelo-monocytic HL-60 Cell Line
J. Gabrilovac, D. Breljak and B.
Èupiæ
Effect of a Single Seizure on Murine Brain Microglia/Macrophages
D.B. Ginsburg, J.I. Silverberg, V.E.
Amassian, R. Orman, M. Stewart and H.G. Durkin
Regulation of Immune Cell Function by a Non-neuronal
Cholinergic System
K. Kawashima, K. Yoshikawa, Y.X. Fujii, Y.
Moriwaki and H. Misawa
Tumor Necrosis Factor Receptor in
Trimethyltin-induced Dentate Granule Cell Death
G.J. Harry, C. Lefebvre d’Hellencourt, R.
Wine and M. Aoyama
Immunological and Neurological Roles of 80-kDa and
100-kDa Haemopoietic Factors
A. Kikuchi, H. Tomoyasu, M. Kobayashi, N.
Sakuragawa and I. Kamo
Salivary Secretory Immunoglobulin A Modulation
Induced by Repetitive Stressful Task and the Mathematical Model of the
Modulation
S. Nomura
Endoplasmic Reticulum-resident Heat Shock Protein
Gp96 as an Innate Sensor Of Damage Induced by Tissue Remodelling, Stress
and Bacterial Peptidoglycan
H. Jakovac, D. Grebiæ,
I. Mrakovèiæ-Sutiæ,
J. Tomac, D. Rukavina and B. Radoševiæ-Stašiæ
A New Murine Model to Study Lymphocyte Migration Into
Brain After a Seizure
J. Silverberg, D. Ginsburg, V. Amassian, R.
Orman, M. Stewart and H. Durkin
Oxidation Detected by Ultra-weak Chemiluminescence
May Be Related to Neural-immune Interactions Under Acute Psychological
Stress
H. Tsuboi, N. Goi, N. Kinae, H. Harada, M.
Hiramatsu, K. Nakamura and K. Takagi
Immune effect on neural
degeneration, regeneration, neurogenesis
The Role of CX3CR1 in Aminoglycoside Ototoxicity
E. Sato, R.M. Ransohoff and K. Hirose
Role of Cytokines in Murine Model of Parkinson’s
Disease (PD) - Gender and Age-related Differences
A. Ciesielska, I. Joniec, A. Przybylkowski,
I. Kurkowska-Jastrzebska, A. Czlonkowska and A. Czlonkowski
Role of PARP-1 in the Genesis and Development of the
Oncogenic Process
L. Castro, I.C. Piedras, C. Gonzalez-Lopez
del Castillo, V.M. Arce and J.A. Costoya
Correlation Between Striatal Dopamine Concentration
and iNOS Expression in Murine Model of Parkinson’s Disease
I. Joniec, A. Ciesielska, A. Przybylkowski,
I. Kurkowska-Jastrzebska, A. Czlonkowska and A. Czlonkowski
Cytokines and Neurosteroids on NaF-induced Neuronal
Cell Death of Neuro2A
A. Kagaya, M. Takebayashi, S. Morinobu and
S. Yamawaki
IL-1 b
Production by Differentiating TF-1 Bone Marrow Progenitor Cells
A. Alexaki, A. Banerjee, E. Kilareski, M.
Nonnemacher and B. Wigdahl
Modulation of Neural Activity-related Gene Expression
in the Olfactory Bulb of Mice Exposed To Toluene
Sohel Ahmed, Tin-Tin-Win-Shwe, Shoji
Yamamoto, Shinji Tsukahara, Yoshika Kurokawa, Daisuke Nakajima, Sumio
Goto and Hidekazu Fujimaki
Cytokine Involvement in Neurodegenerative Disorders
M. Reale, D. Gambi, M. Onofrj, A. Thomas
and C. Iarlori
Autoimmune Reaction Protects Neurons Injured with
1-methyl-4-phenyl-1,2,3,6-tetrahydropiridine (MPTP) in Mice
I. Kurkowska-Jastrzêbska,
I. Joniec, A. Ciesielska, E. Ba³kowiec-Iskra,
A. Cz³onkowski
and A. Cz³onkowska
C5 b-9
Terminal Complex Protects Oligodendrocytes from Apoptotic Cell Death
C. Cudrici, F. Niculescu, T. Jansen, E.
Zafranskaia, M. Fosbrink, S. Vlaicu, V. Rus, M. L. Shin and H. Rus
Thioredoxin Modulates NMDA-induced Retinal
Neurotoxicity in Rat
Y. Inomata, H. Nakamura, M. Tanito, A.
Teratani, T. Kawaji, N. Kondo, J. Yodoi and H. Tanihara
Immune Cell-based Regulation of Adult Neurogenesis
Y. Ziv, N. Ron, H. Avidan, A. Finkelstien,
O. Butovsky, J. Kipnis, E. Yoles and M. Schwartz
Late Arrivals
High Motor Active Rats in Novel Environment (HR)
Compared to Low Motor Active (LR) Rats Are Not Better Protected Against
Cancer
M.K. Jurkowski and B. Bobek-Billewicz
|